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Dysmorphism of urinary red blood cells—Value in diagnosis. To aid
investigation into the clinical problem of hematuria, assessment of
abnormalities in the shape of red cells in the urine (dysmorphism) is
gaining popularity in nephrology. However, there is uncertainty in the
literature regarding both the number of red blood cells (RBC) in normal
urine, as well as the quantification of dysmorphism. We have shown
that in normal urine (N = 27) the number of RBC is less than 2,000/mI
as assessed by scanning electron microscopy of filtered urine specimens
from normal volunteers without known renal disease, which compared
to less than I ,000/ml by centrifugation and phase contrast microscopy
of the same specimen. To determine whether dysmorphism of urinary
red blood cells was a significant predictor of glomerular disease we
compared the number of dysmorphic cells in the urine of patients with
biopsy proven glomerulonephritis (ON), before and immediately after
renal biopsy. We also compared the number of dysmorphic cells in
patients with glomerulonephritis to those with lower urinary tract
bleeding. Renal biopsy caused significant dysmorhpic hematuria, indi-
cating that dysmorphism suggests renal rather than glomerular bleed-
ing. Although patients with ON had significantly more dysmorphic
urinary RBC when compared to those with lower tract urinary bleeding,
the overlap was such that one could only be confident of renal
hematuria if they accounted for greater than 75% of the total number of
RBC. Non renal hematuria is present if number of dysmorphic cells is
less than 17% of total RBC. Thus dysmorphism of urinary RBC is a
useful diagnostic tool, but only if strict criteria established for each
laboratory are adhered to.
There exists in the literature widespread disagreement and
conflicting criteria regarding the level of hematuria which
becomes pathologically significant and thus warrants investiga-
tion, especially in relation to the value of dysmorphism of
urinary red blood cells as a guide to the etiology of hematuria.
For instance, Birch and Fairley [1] quoted less than 2,000 red
blood cells (RBC)/ml, Fairley and Birch [21 and Birch et a! [31
less than 8,000 dysmorphic RBCIm1, and Fassett, Horgan and
Matthew [4] less than 3,000 RBC/ml as normal, while Ihle, Long
and Oats [5] considered less than 8,000 RBC/ml as normal but
only performed a renal biopsy if the number of cells exceeded
20,000 RBC/ml, while still others only looked for dysmorphism
itself [6] without regard to the number of red cells. Similarly,
there is uncertainty as to how much dysmorphism can be
considered normal and how various investigators have arrived
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at their criteria. There are several reports [3, 4, 7] which quote
a figure of greater than 80% dysmorphic cells as indicating
glomerular bleeding, but give no details as to how this figure
was derived. Conversely, others regard greater than 10% to
14% of dysmorphic RBC as indicating glomerular pathology [8,
9], and others find mixed RBC morphology in glomerular, renal
and lower urinary tract bleeding [10]. Since this technique is
becoming increasingly used in nephrology and the problems
outlined obviously cast serious doubt on the scientific basis
underlying it which could lead to serious omissions of appro-
priate investigations, the present study was undertaken with the
following aims:
1. To determine the number of red blood cells (RB C) in the
urine of healthy volunteers by a centrifugation-independent
method, and compare the values thus obtained with those
using routine laboratory phase contrast microscopy on the
same urine samples.
2. To compare the urine from patients with biopsy proven
glomerulonephritis and those with proven lower urinary
tract bleeding with respect to the content of dysmorphic
RBC (DRBC), and define the limits of dysmorphism in these
two conditions.
3. To determine the type of cell excreted in the hematuria
caused by renal biopsy.
4. To establish the routine predictive value of RBC in the urine
of patients undergoing routine renal function testing.
Methods
Red cell counting
To determine the total number of all RBC in the urine of
volunteers without a known history of renal disease and inde-
pendent of centrifugation, urinary red cells of all shapes and
sizes were counted by scanning electron microscopy (SEM) of
a filtered specimen and compared to a routine phase contrast
microscopy (PCM) method. The total number of RBC in the
urine of 27 volunteers was determined by phase contrast
microscopy using 10 ml of a well stirred, early morning speci-
men of urine centrifuged at 2,000 rpm for four minutes; 9.5ml
of supernatant was discarded and the remainder resuspended
and counted in a Fuchs Rosenthal counting chamber, as pub-
lished previously [11]. Briefly, the entire field of the chamber
(16 large squares, 0.0032 ml) is searched for casts and (16 small
square, 0.0002 ml) are searched for red blood cells. A further 40
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ml of the same urine had 25% glutaraldehyde added to it, and
half of this was used to determine normal urinary RBC by SEM.
For SEM, the samples were filtered through a 25 mm diam-
eter ifiter paper with 2 pore size (Millipore Corp., Bedford,
Massachusetts, USA) using a syringe. The filter papers were
then dehydrated by slowly passing them through a graded series
of ethanol concentrations (30, 50, 70, 90% and absolute) and
then allowed to dry in air. Five 200 mesh grids were placed over
the filter paper, and this was then sputter coated to give a 20 nm
gold film. The number of recognizable RBC contained in 20
random squares, four from each grid of the filter paper, were
counted in a J.E.O.L. SEM (JEOL, Tokyo, Japan) at 1,500
magnification and converted to RBC/nil. All recognizable RBC,
irrespective of shape were counted and in doubtful cases
magnification was increased, This method of counting cells on a
filter paper was validated by counting a known number of red
cells (500, 1,000 and 5,000 RBC/ml, N = 18). These were
obtained from a stock solution of blood from a normal volunteer
in which the total number of RBC were determined in a Coulter
counter, in duplicate and from hernatocrit measurements.
Packed cells were then obtained from this by centrifugation.
and the stock solution made up in 25% glutaraldehyde to
contain 5 x l0 RBC/ml in a final glutaraldehyde concentration
of 2.5%. Further dilutions were then made, immediately before
use as desired, in 0.9% saline.
For each urine sample of a normal volunteer, the method was
further checked by performing recovery assays on the urines by
adding a known number of RBC to another portion of the urine.
The dilutions and number of RBC in the stock solutions were
checked each run by also counting the dilutions themselves.
Patient material
Thirty-one consecutive patients undergoing percutaneous
renal biopsy for indications as determined by their specialists,
had a first morning specimen of urine examined by phase
contrast microscopy on the day of biopsy and also on the
morning following the biopsy. Urine was tested for pH and
blood with an analytical reagent strip.
If microscopy was not undertaken immediately the urine was
fixed with 0.5 ml 16% formalin for later counting, which
occurred in 14 specimens following biopsy. The total number of
RBC, and numbers of normal and dysmorphic RBC were
counted. Cells were regarded as dysmorphic if they exhibited a
wide range of morphological variation frequently with loss of
hemoglobin, and normal if not more than two cell populations
were present, either well hemogloblinized with a relatively
normal appearance or showed loss of hemoglobin or other
minor changes, according to the criteria of Birch et al [3]. A
minimum of 20 RBC were counted each time to ensure an
adequate representation of RBC morphology. Assuming that
the increase in urinary RBC excretion following renal biopsy
was traumatic in origin and thus normomorphic in nature, the
expected fraction of normomorphic cells past biopsy was cal-
culated by the following equation:
Normomorphic cells pre-biopsy + Increase in total RBC
Total RBC post-biopsy
and expressed as a percentage.
A further 28 patients with proven lower urinary tract bleeding
(renal calculi and bladder tumours) also had their first morning
urine specimen examined immediately for the number of normal
and dysmorphic cells by phase contrast microscopy. These
patients had normal renal function as assessed by a normal
creatinine clearance, no casts [121 evident in an early morning
specimen of urine and no history of renal disease. Although
renal biopsy could not ethically be performed on these patients
to definitively exclude coincident renal parenchymal disease, it
was assumed the etiology of hematuria in these patients was
due to lower urinary tract bleeding.
To assess the practicality of routine urine examination for
dysmorphic cells, 64 consecutive patients referred for renal
function testing had their early morning urine examined by
PCM for dysmorphic cells as outlined above.
The presumptive diagnoses of these patients and the corre-
lation with urine microscopy were only established when all the
64 results were available. The patients were considered to have
glomerular disease if they either had [1] a history of, and/or
biopsy proven glomerulonephritis and had no history of kidney
stone disease, pyelonephritis, reflux nephropathy, or analgesic
abuse, or [2], in the absence of any positive history, if the renal
function tests [12] showed an abnormal GFR only, without a
specific concentrating or acidification defect (independent of
GFR). They were considered to have medullary disease if [1]
they did not have either a history and/or biopsy proof of
glomerulonephritis and had a history of any of the following:
kidney stone disease, pyelonephritis, reflux nephropathy or
analgesic abuse in the presence of a concentrating or acidifica-
tion defect, or [21 in the absence of any positive history, if they
either had a specific concentrating defect (that is, independent
of GFR abnormalities) and/or an acidification defect. Seventeen
patients did not fit clearly into either of the two categories.
Phase-contrast urine microscopy was performed by two
observers who were blinded to the final diagnosis. Uniformity
in the interpretation of RBC morphology was achieved by dual
examination of 21 urine specimens which demonstrated close
agreement in recognition of dysmorphic cells (r 0.85). In
eleven of these cases initial examination was performed on
freshly voided urine and subsequent examination was done
after fixation in 0.5 ml of 16% formalin. Similar agreement in
recognition of dysmorphic cells was seen (r = 0.89) indicating
that fixation had no effect on RBC morphology. Histological
lesions were regarded as mild if light microscopy revealed
minimal abnormality, the majority of pathology demonstrated
on immunofluorescence or electron microscopy and creatinine
clearance was greater than 80 mI/mm, moderate if light micro-
scopic (± immunofluorescence and electron microscopy abnor-
malities) were evident in association with a creatinine clearance
of greater than 60 mls/min and severe if proliferative or inflam-
matory lesions were evident in association with a creatinine
clearance of less than 50 ml/min.
Statistical analysis of patients undergoing renal biopsy was
made using a paired t-test. Other analyses were made using a
two-sample I-test
For the purposes of comparison unless otherwise stated,
crenated cells were regarded as dysmorphic, since according to
Birch et al [3] these cells exhibited a wide range of morpholog-
ical variation and thus fulfilled the criteria for dysmorphism.
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Table 1. Validation of scanning electron microscopic method of
counting red blood cells and comparison of number of red blood cells
in normal human urine by phase contrast and scanning electron
microscopy
Validation of SEM Normal urinary RBC in counting
in counting RBC comparison of PCM & SEM
Scanning Scanning
Known no. electron Phase contrast electron
of cells microscopy microscopy microscopy
500 554 58 (5) 203 72 (27) 526 142
1000 1054 99 (8) (949)8 (2206)8
5000 5194 264 (5) (()_1750)b (94_3570)b
Correlation
r 0.982 0.814
P 0.001 0.001
Pre biopsy
(26)
Post biopsy
(26)
Lower tract
bleeding
(28)
Total 29123 11038 331327 226251 98446 23642
RBC/ml
Dysmorphic 65.7 4.8 62.6 5.6 48.5 2.5
RBC %
Results
The SEM method of counting red cells of a filtered specimen
was well validated with a correlation coefficient of 0.98 (Table
1) using a known number of RBC in saline. Similarly, the
recovery rate of a known number of RBC in urine was 97%.
Both indicate a high degree of reliability of the technique.
Determination of the number of RBC in normal volunteers'
urine is summarized in Table 1, confirming that normal urine
contains <1,000 RBC/ml as assessed by PCM (95% confi-
dence). SEM showed higher RBC excretion rates, as expected,
with a mean of 726 RBC/ml (2,206 RBC/ml, 95% upper limit).
Of the 31 patients who underwent renal biopsy, 26 patients
increased their urinary rbc excretion following biopsy by
303,203 116,818 (mean SE). The remaining five patients had
fewer urinary RBC/ml following biopsy. Since the aim of the
study was to determine the type of red cell excreted due to the
biopsy, these five patients were not considered further. Table 2
demonstrates that there was no difference in the percentage of
dysmorphic RBC seen in the urine following biopsy compared
with pre-biopsy. This was true whether crenated cells were
regarded as dysmorphic or normomorphic, and as their mor-
phology varied widely and criteria for dysmorphism is unclear,
they were subsequently regarded as dysmorphic (57.4 5.4%,
56.0 6.1 and 31.6 2.1% without crenated cells respectively,
Table 2). If the increase in total RBC excretion seen after renal
biopsy was all "non-glomerular" in nature, 84.4% 3.76 of
total urinary RBC following renal biopsy (Methods) would be
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expected to be of normal morphology as opposed to the
observed 37.3 5.2% (53%of the increase in RBC, rather than
100% of the increase, Fig. 1). This difference between observed
and expected percentages of normal RBC was statistically
highly significant (P < 0.0001). Histological diagnosis included
IgA nephropathy —8, mesangial proliferative glomerulonephri-
tis (IgA negative) —2, membranous glomerulonephritis —4,
focal sclerosing glomerulonephritis —2, focal necrotizing gb-
merulonephritis —1, transplant rejection —2, post-infectious
gbomerulonephritis —1, afferent arteriolar C3 deposition or thin
basement membrane disease — 11. Histological severity of the
glomerulonephritis was graded as severe (N = 7), moderate (N
= 13), or mild (N = 11), and there was no difference in degree
of urinary RBC dysmorphism among the three groups being
72% 15, 55% 22 and 78% 22 and 78% 25, respectively.
The results of the 28 patients with lower urinary tract
bleeding are presented in Table 2. They had significantly lower
percentage of dysmorphic cells when compared with the pa-
tients with biopsy proven glomerulonephritis (49% vs. 66%, P
<0.005). However, the range of values obtained were such that
when considering the 95% confidence limits, considerable over-
lap occurred, as illustrated in Figure 2. Some patients with
histologically-proven glomerular pathology had only 17% dys-
morphic cells, whereas some patients with lower urinary tract
bleeding had up to 75% dysmorphic cells.
If up to 8,000 dysmorphic RBC are regarded as normal, as
defined by Birch et al [31, 10 patients with glomenibonephritis
and 26 patients with lower tract hematuria had abnormal
numbers of dysmorphic red cells in their urine. Of the 16
patients with gbomerulonephritis with less than 8,000 dysmor-
phic RBC, 15 patients had >2,000 normal RBC, and one patient
had 7,000 RBC of which 6,750 were dysmorphic. When the
patients were compared according to these criteria with 8,000
dysmorphic RBC excluded from the initial number of dysmor-
phic cells and then recalculated as a percentage, there was no
significant difference between the dysmorphic RBC in the urine
of patients with glomerulonephritis (58.1 33.2 SD) or lower
urinary tract bleeding (41.0 19.1% SD, P> 0.05).
The results of the 64 patients undergoing renal function
testing with respect to morphology of RBC is shown in Table 3.
The percentage of dysmorphic cells in patients with glomerular,
Expected Observed
0—
Data presented are means SEM. Number in parentheses are the
number of samples.
a Upper 95% levelb Actual range
Table 2. Comparison of hematuria pre- and post-biopsy in patients
with glomerulonephritis and in patients with lower urinary tract
bleeding
Pre-biopsy Post-biopsy
Fig. 1. Hematuria before and following renal biopsy normomorphic
cells indicated by solid bar, dysmorphic by open bar. Also indicated is
the expected number of normomorphic cells post-biopsy (100%) versus
number actually observed (53%, P < 0.001).
Data presented are means SEM.
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Table 3. Comparison of number of red blood cells and degree of
dysmorphism in 64 patients undergoing one-day renal function testing
with significant hematuria (>1000 RBC/ml)
Total number of Percent
RBC (per ml) dysmorphic
Glomerular (16) 32 9.4 x l0 67 4.9
No. of patients with 6/16
>75% dysmorphic cells
Medullary (25) 13656 4.5 X iO 63 4.2
No. of patients with 0/25
>17% of dysmorphic cells
Uncertain (17) 160 138 x l0 75 3.7
No hematuria (6) 708 70 66 5.5
Number in parentheses are number of patients
hematuria (>1,000 RBC/ml).
Data are presented as mean 5EM.
with significant
medullary or uncertain etiology, as previously defined (Meth-
ods), was not significantly different.
The number of crenated RBC, but not those of dysmorphic
cells, increased significantly with increasing pH (r = 0.41, P <
0.04). This strongly implies that the mechanisms responsible for
producing dysmorphism are very different to those producing
crenation. However, since previous workers have regarded
crenated cells as dysmorphic, for reasons of comparison, in this
paper we have also counted them as dysmorphic unless other-
wise stated. In addition, as pointed out above, inclusion or
exclusion of crenated cells in the analysis in no way altered the
conclusions this study led us to.
Discussion
Hematuria is a common diagnostic problem in clinical prac-
tice. With the aid of sensitive dip-stick analysis of urine more
patients are referred for investigation of microscopic hematuria.
However, there remains controversy in the literature regarding
the level at which hematuria is a cause of concern.
Birch and Fairley in their initial report of dysmorphism of
urinary RBC as a guide to renal pathology regarded up to 2,000
FIg. 2. Degree of hematuria (A) and percent
dysmorphism (B) in patients with proven
glomerulonephritis (Li) and with lower tract bleeding
(VA). The latter had significantly lower percentage
dysmorphism than patients with glomerulonephritis. The
overlap in dysmorphic cells between the groups (±2 so)
demonstrates that some patients with lower urinary
tract bleeding had up to 75% dysmorphic cells, and
some patients with glomerular bleeding had as few as
17% dysmorphic cells.
RBC/ml as being normal [11, however, in subsequent reports
they regard up to 8,000 dysmorphic RBC/ml as normal [2, 3].
Others have regarded greater than 3,000 RBC/ml as abnormal
regardless of RBC morphology [4].
We have previously shown that the upper limit of normal
urinary red cell excretion was up to 1,000/mIll!, 131, and the
current report confirms this with the "gold standard" tech-
nique. By using SEM and a filtering technique, all urinary RBC
are counted and a much higher degree of accuracy can be
achieved. The higher values obtained with SEM is not surpris-
ing as not all cells could be expected to be sedimented by
centrifugation. We, as others [4] cannot regard 8,000 RBC/ml as
normal, The reason for this discrepancy is unclear as the sole
difference in methodology is the examination of early morning
as opposed to random urine samples, but it is difficult to accept
that phase contrast microscopy would offer a better degree of
resolution than scanning electron microscopy. On the contrary,
we have great difficulty in being sure when a fragment, as seen
in the PCM is indeed part of a cell or just unrecognizable
sediment (crystals, etc.).
Dysmorphism of urinary rbc has been regarded as an indica-
tor of glomerular pathology [3, 4, 7—9, 13, 14]. However, at
what level dysmorphic RBC becomes significant is also unclear.
Birch and Fairley [1, 21 regarded up to 8,000 dysmorphic cells
as normal and accordingly exclude this amount when assessing
urinary RBC with respect to morphology. They recommend
investigation of the lower urinary tract in all patients with any
normomorphic urinary RBC. Others assess the pathology to be
glomerular if >80% RBC are dysmorphic and non-glomerular if
>80% RBC are normomorphic [4, 7] and still others regard
>10% dysmorphism to be indicative of glomerular bleeding [81.
Thus, many patients assessed by the latter criteria as having
glomerular bleeding would have lower urinary tract bleeding
when assessed by the criteria of Birch and Fairley [1, 2].
The present study indicates that while patients with glomer-
ulonephritis have significantly larger percentages of dysmorphic
RBC, it is only useful as an adjuvant in diagnosis if the
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percentage exceeds >75%. At levels below this lower urinary
tract bleeding remains a possibility.
Furthermore, the study demonstrates that dysmorphism of
urinary RBC is a non-specific indicator of renal pathology and
not indicative of purely glomerular disease as evidenced by the
fact that patients undergoing renal biopsy had equivalent per-
centages of dysmorphic RBC both pre- and post-biopsy. Al-
though the results from patients undergoing renal function
testing are less rigorous, the fact that patients with glomerular
or medullary pathology could not be separated according to the
dysmorphism of urinary RBC, would underscore the need to be
extremely cautious in labelling any patient's significant hema-
tuna as of either glomerular or lower tract origin. Since dys-
morphism is not indicative only of glomerular bleeding but of
renal bleeding, patients with significant interstitial disease, such
as due to analgesic nephropathy or connective tissue diseases
might also demonstrate significant (by our criteria) dysmor-
phism of their urinary RBC.
We thus conclude that, by phase contrast microscopy, nor-
mal urine contains less than I ,000 RB C/mi and that dysmor-
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phism of urinary RBC is a useful clinical predictor of renal
pathology (not purely glomerular) as opposed to lower urinary
tract bleeding, only if they account for greater than 75% of the
total number of urinary RBC. Lower urinary tract bleeding, on
the other hand, can only be diagnosed with certainty with this
technique if there are more than 83% non-dysmorphic cells
present. At levels between these two extremes the finding of
dysmorphic RBC is non-specific in nature and investigation of
hematuria should proceed according to other parameters such
as history, presence of proteinuria, tubular defects and the
presence or absence of casts in the first morning specimen of
urine [11].
